GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (OTCPK:LZAGY) » Definitions » Total Stockholders Equity

Lonza Group (Lonza Group) Total Stockholders Equity : $10,930 Mil (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Lonza Group Total Stockholders Equity?

Lonza Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $10,930 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Lonza Group's Book Value per Share for the quarter that ended in Dec. 2023 was $15.16. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Lonza Group's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.33.

Lonza Group Total Stockholders Equity Historical Data

The historical data trend for Lonza Group's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lonza Group Total Stockholders Equity Chart

Lonza Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,609.00 7,671.09 10,586.32 11,375.05 10,929.70

Lonza Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,586.32 10,318.49 11,375.05 11,446.02 10,929.70

Lonza Group  (OTCPK:LZAGY) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Lonza Group's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(10929.695-0)/721.166
=15.16

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Lonza Group's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(262.488 + 3359.158) / 10929.695
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lonza Group Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Lonza Group's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Lonza Group (Lonza Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (OTCPK:LZAGY) » Definitions » Total Stockholders Equity
Comparable Companies
XSWX:EMMN XSWX:ARYN XSWX:ORON XSWX:BARN XSWX:BELL XSWX:GMI XSWX:HOCN XSWX:GALD TSE:2309 TMO DHR IQV IDXX A MTD ICLR ILMN WAT SHSE:603259 LH
Traded in Other Exchanges
LZAGF:USA LONN:Mexico LONNz:UK LO3A:Germany LONNE:Switzerland LONN:Switzerland
Address
Muenchensteinerstrasse 38, Basel, CHE, CH-4002
Website
https://www.lonza.com
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.